Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Tetramethylammonium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 1/20 | 0.67 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.67 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetramethylammonium Ion SCHEMBL2544926 | 1.00 | — | — | |
| Tetramethylammonium Ion SCHEMBL480154 | 1.00 | — | — | |
| Tetramethylammonium Ion SCHEMBL9312713 | 1.00 | CHRNB2 (0.67) | CHRNB2CHRNA7CHRNA4 | |
| Tetramethylammonium Ion SCHEMBL9191344 | 1.00 | CHRNB2 (0.67) | CHRNB2CHRNA7CHRNA4 | |
| Tetramethylammonium Ion SCHEMBL27445622 | 0.93 | — | — | |
| Tetramethylammonium Ion SCHEMBL18515 | 0.91 | — | — | |
| Tetramethylammonium Ion SCHEMBL8586405 | 0.91 | CHRNB2 (0.80) | CHRNB2CHRNA7CHRNA4 | |
| Tetramethylammonium Ion SCHEMBL5684461 | 0.91 | — | — | |
| Tetramethylammonium Ion SCHEMBL781770 | 0.91 | CHRNB2 (0.80) | CHRNB2CHRNA7CHRNA4 | |
| Tetramethylammonium Ion SCHEMBL7028672 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 246 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117143592-B | Mn (Mn)4+Activated fluoride (oxide) red fluorescent material and preparation method thereof | 华南理工大学 | 2026-05-22 | — | — | CN | claimed |
| US-20260048990-A1 | METHODS FOR SYNTHESIZING MXENES VIA SUPERCRITICAL FLUID PROCESS | BALLYDEL TECH INC (US) | 2026-02-19 | — | — | US | claimed |
| US-20250345644-A1 | FIRE RETARDANT COMPOSITIONS CONTAINING A CARBONATE SALT AND ONE OR MORE CORROSION INHIBITORS | PERIMETER SOLUTIONS LP | 2025-11-13 | — | — | US | claimed |
| CN-116143809-B | High-stability rare earth nano fluorine cluster for LED illumination, and method and application thereof | 西安交通大学 | 2024-11-22 | — | — | CN | claimed |
| CN-116143810-B | Gadolinium-based nano fluorine cluster for magnetic refrigeration and preparation method thereof | 西安交通大学 | 2024-11-22 | — | — | CN | claimed |
| CN-118791342-A | Method for optimizing TATB performance based on curing effect | 西南科技大学 | 2024-10-18 | — | — | CN | claimed |
| CN-117039207-B | Battery, iodine electrode material and preparation method of electrolyte | 广东工业大学 | 2024-07-30 | — | — | CN | claimed |
| CN-113735880-B | Preparation method of everolimus and intermediate thereof | 鲁南制药集团股份有限公司 | 2023-12-22 | — | — | CN | claimed |
| CN-117143592-A | Mn (Mn) 4+ Activated fluoride (oxide) red fluorescent material and preparation method thereof | 华南理工大学 | 2023-12-01 | — | — | CN | claimed |
| CN-117039207-A | Battery, iodine electrode material and preparation method of electrolyte | 广东工业大学 | 2023-11-10 | — | — | CN | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| US-5922117-A | Ink compositions containing alcohols | XEROX CORPORATION (US) | 1999-07-13 | — | — | US | claimed |
| US-5759727-A | TONER IMAGE ON TRANSPARENT SUBSTRATE; MELT POLYMER BACKING | XEROX CORPORATION (US) | 1998-06-02 | — | — | US | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| US-5338521-A | Process for reversibly absorbing acid gases from gaseous mixtures | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1994-08-16 | — | — | US | claimed |
| EP-0311903-B1 | MOLTEN SALT HYDRATE MEMBRANES FOR THE SEPARATION OF GASES | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1992-09-09 | — | — | EP | claimed |
| US-4973456-A | QUATERNARY AMMONIUM CARBOXYLATES, ALKALI METAL FLUORIDES | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1990-11-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260048990-A1 | METHODS FOR SYNTHESIZING MXENES VIA SUPERCRITICAL FLUID PROCESS | FGF2, FGFR2, VEGFA | CHRNB2 4685/4885CHRNA7 4880/4885CHRNA4 4838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.